Scinai Immunotherapeutics Ltd. (SCNI)
0.4844
+0.04
(+9.84%)
USD |
NASDAQ |
Nov 09, 16:00
0.479
-0.01
(-1.11%)
After-Hours: 19:48
Scinai Immunotherapeutics Enterprise Value : 7.709M for Nov. 6, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 06, 2026 | 7.709M |
| November 05, 2026 | 7.722M |
| November 04, 2026 | 7.719M |
| November 03, 2026 | 7.751M |
| November 02, 2026 | 7.754M |
| October 30, 2026 | 7.750M |
| October 29, 2026 | 7.814M |
| October 28, 2026 | 7.835M |
| October 27, 2026 | 7.830M |
| October 26, 2026 | 7.845M |
| October 23, 2026 | 7.876M |
| October 22, 2026 | 7.939M |
| October 21, 2026 | 7.938M |
| October 20, 2026 | 8.034M |
| October 19, 2026 | 8.127M |
| October 16, 2026 | 8.130M |
| October 15, 2026 | 8.332M |
| October 14, 2026 | 8.303M |
| October 13, 2026 | 8.776M |
| October 12, 2026 | 8.682M |
| October 09, 2026 | 8.709M |
| October 08, 2026 | 8.749M |
| October 07, 2026 | 8.641M |
| October 06, 2026 | 8.763M |
| October 05, 2026 | 8.817M |
| Date | Value |
|---|---|
| October 02, 2026 | 8.912M |
| October 01, 2026 | 8.885M |
| September 30, 2026 | 9.034M |
| September 29, 2026 | 7.158M |
| September 28, 2026 | 7.192M |
| September 25, 2026 | 7.238M |
| September 24, 2026 | 7.414M |
| September 23, 2026 | 7.483M |
| September 22, 2026 | 7.443M |
| September 21, 2026 | 7.317M |
| September 18, 2026 | 7.243M |
| September 17, 2026 | 7.277M |
| September 16, 2026 | 7.220M |
| September 15, 2026 | 7.232M |
| September 14, 2026 | 7.745M |
| September 11, 2026 | 7.300M |
| September 10, 2026 | 7.306M |
| September 09, 2026 | 7.329M |
| September 08, 2026 | 7.323M |
| September 04, 2026 | 7.414M |
| September 03, 2026 | 7.466M |
| September 02, 2026 | 7.688M |
| September 01, 2026 | 7.756M |
| August 31, 2026 | 7.779M |
| August 28, 2026 | 7.785M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Compugen Ltd. | 63.38M |
| Pluri, Inc. | 46.05M |
| Evogene Ltd. | 5.476M |
| CollPlant Biotechnologies Ltd. | 5.443M |
| Regentis Biomaterials Ltd. | 50.73M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -1.951M |
| Revenue (Quarterly) | 1.841M |
| Total Expenses (Quarterly) | 3.791M |
| EPS Diluted (Quarterly) | -2.777 |
| Gross Profit Margin (Quarterly) | -32.38% |
| Profit Margin (Quarterly) | -106.0% |
| Earnings Yield | 5.97K% |